Your browser doesn't support javascript.
loading
Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice.
Akiyama, Kazumasa; Shimada, Yohta; Higuchi, Takashi; Ohtsu, Makoto; Nakauchi, Hiromitsu; Kobayashi, Hiroshi; Fukuda, Takahiro; Ida, Hiroyuki; Eto, Yoshikatsu; Crawford, Brett E; Brown, Jillian R; Ohashi, Toya.
Afiliação
  • Akiyama K; Department of Gene Therapy, Institute of DNA Medicine, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan; Department of Pediatrics, Kitasato University Graduate School of Medicine, Kanagawa, Japan.
  • Shimada Y; Department of Gene Therapy, Institute of DNA Medicine, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.
  • Higuchi T; Department of Gene Therapy, Institute of DNA Medicine, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.
  • Ohtsu M; Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Nakauchi H; Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kobayashi H; Department of Gene Therapy, Institute of DNA Medicine, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan; Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
  • Fukuda T; Division of Neuropathology, Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
  • Ida H; Department of Gene Therapy, Institute of DNA Medicine, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan; Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
  • Eto Y; Advanced Clinical Research Center, Institute of Neurological Disorders, Kanagawa, Japan.
  • Crawford BE; BioMarin Pharmaceutical Inc., San Diego, CA, USA.
  • Brown JR; BioMarin Pharmaceutical Inc., San Diego, CA, USA.
  • Ohashi T; Department of Gene Therapy, Institute of DNA Medicine, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan; Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: tohashi@jikei.ac.jp.
Mol Genet Metab ; 111(2): 139-46, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24100247
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Mucopolissacaridose II / Iduronato Sulfatase Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Mucopolissacaridose II / Iduronato Sulfatase Idioma: En Ano de publicação: 2014 Tipo de documento: Article